{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:45Z","timestamp":1786119525383,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The T-SPOT.\n                      <jats:italic toggle=\"yes\">TB<\/jats:italic>\n                      , an interferon-gamma release assay, is an indirect test of\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      infection. Due to sparse and conflicting evidence, the use of interferon-gamma release assay is limited in young and HIV-infected children. We determined the prevalence of invalid, borderline, positive and negative results and associations with key demographic variables during routine pediatric use in a low tuberculosis burden setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>For pediatric samples received at Oxford Diagnostic Laboratories between 2010 and 2015, the associations between initial test outcome and demographics were estimated by bivariate analysis and logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 44,289 samples (median age 12.5 years; interquartile range 7.7\u201315.5), including 5057 samples (11.6%) from children under 5 years old, were received from 46 U.S. states, Washington, DC and Puerto Rico. A total of 592 samples (1.3%) could not be tested. T-SPOT.\n                      <jats:italic toggle=\"yes\">TB<\/jats:italic>\n                      positivity was strongly correlated (r = 0.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) with state TB incidence. Compared with negative results, positive results were more likely in samples from older children (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001), public health clinics (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) and rural locations (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005). Although infrequent (0.6%), invalid results were more common in samples collected at HIV clinics (odds ratio = 2.5, 95% confidence interval: 1.3\u20134.9) and from younger children (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03). These invalid results were more likely due to a robust nil (negative) control response rather than a weak mitogen (positive) control response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The T-SPOT.\n                      <jats:italic toggle=\"yes\">TB<\/jats:italic>\n                      test correlated strongly with well-recognized risk factors for tuberculosis infection and provided evaluable results in 98% of children. To optimize the impact of testing on clinical decision making and patient outcomes, local epidemiology and individual patient risk should be considered when incorporating IGRAs into pediatric guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000001792","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T15:47:59Z","timestamp":1510760879000},"page":"292-297","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["T-SPOT.TB Performance in Routine Pediatric Practice in a Low TB Burden Setting"],"prefix":"10.1097","volume":"37","author":[{"given":"Anna M.","family":"Mandalakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Y.","family":"Highsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pawlicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Lester","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(16)30132-3","article-title":"Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.","volume":"16","author":"Dodd","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new end TB strategy.","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis.","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201406-1165OC","article-title":"Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.","volume":"191","author":"Mandalakas","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","article-title":"Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.","volume":"361","author":"Ewer","year":"2003","journal-title":"Lancet"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"e105003","DOI":"10.1371\/journal.pone.0105003","article-title":"Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure.","volume":"9","author":"Tieu","year":"2014","journal-title":"PLoS One"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpeds.2012.04.007","article-title":"The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection.","volume":"161","author":"Critselis","year":"2012","journal-title":"J Pediatr"},{"key":"R12-20260107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ejcn.2013.216","article-title":"Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis.","volume":"68","author":"Mukherjee","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying predictors of interferon-\u03b3 release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study.","volume":"186","author":"Basu Roy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"R14-20260107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2500\/aap.2012.33.3574","article-title":"Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs).","volume":"33","author":"Riazi","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/INF.0b013e31827d77b7","article-title":"Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction.","volume":"32","author":"Mandalakas","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20260107","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children.","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R17-20260107","first-page":"689","article-title":"Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer.","volume":"14","author":"Stefan","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R18-20260107","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s15010-013-0450-y","article-title":"Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis.","volume":"41","author":"Carvalho","year":"2013","journal-title":"Infection"},{"key":"R19-20260107","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3201\/eid1809.120128","article-title":"Evaluation of immigrant tuberculosis screening in industrialized countries.","volume":"18","author":"Pareek","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"RR-5","key":"R21-20260107","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010.","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R22-20260107","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1542\/peds.2014-2983","article-title":"Interferon-\u03b3 release assays for diagnosis of tuberculosis infection and disease in children.","volume":"134","author":"Starke","year":"2014","journal-title":"Pediatrics"},{"key":"R26-20260107","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.amepre.2014.02.001","article-title":"Toward a county-level map of tuberculosis rates in the U.S.","volume":"46","author":"Scales","year":"2014","journal-title":"Am J Prev Med"},{"key":"R30-20260107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2011-200933","article-title":"Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.","volume":"68","author":"Mandalakas","year":"2013","journal-title":"Thorax"},{"key":"R31-20260107","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States.","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"R32-20260107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/fmb-2016-0027","article-title":"Managing tuberculosis infection in children in the USA: an update.","volume":"11","author":"Cruz","year":"2016","journal-title":"Future Microbiol"},{"key":"R33-20260107","doi-asserted-by":"crossref","first-page":"282; author reply 282\u2013283","DOI":"10.1016\/S0140-6736(06)69064-8","article-title":"Blood tests for diagnosis of tuberculosis.","volume":"368","author":"Kampmann","year":"2006","journal-title":"Lancet"},{"key":"R34-20260107","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"R35-20260107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20260107","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2334-14-516","article-title":"Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values.","volume":"14","author":"Rose","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R37-20260107","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.humimm.2016.08.001","article-title":"High levels of plasma interferon gamma and +874T\/A gene polymorphism is associated with HIV-TB co-infection.","volume":"77","author":"Gutlapalli","year":"2016","journal-title":"Hum Immunol"},{"key":"R38-20260107","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5588\/ijtld.12.0027","article-title":"Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection.","volume":"16","author":"Mandalakas","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R39-20260107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jpids\/piu024","article-title":"Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto Pediatric TB clinic.","volume":"4","author":"Rose","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R40-20260107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/655129","article-title":"Tuberculosis transmission to young children in a South African community: modeling household and community infection risks.","volume":"51","author":"Wood","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R41-20260107","first-page":"406","article-title":"Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa.","volume":"14","author":"Wood","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R42-20260107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.201501-0199OC","article-title":"T-SPOT.TB interferon-gamma release assay performance in healthcare worker screening at nineteen U.S. hospitals.","volume":"192","author":"King","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R43-20260107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/INF.0000000000000286","article-title":"Disseminated tuberculosis in 2 children with inflammatory bowel disease receiving infliximab.","volume":"33","author":"Cruz","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R44-20260107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12969-015-0054-4","article-title":"Tuberculosis in pediatric patients treated with anti-TNF\u03b1 drugs: a cohort study.","volume":"13","author":"Calzada-Hern\u00e1ndez","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"R46-20260107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence - United States, 2013\u20132015.","volume":"65","author":"Salinas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:44:37Z","timestamp":1786041877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001792","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}